drug thresholds

We recently ran part one of our story on the challenges facing HISA. Today, we deal with lawsuits, adjudication, and more. This time next year, the machinery of horse racing in the U.S. may be almost a month into a radical system overhaul. But with scant few calendar pages between now and then, what do we know about how the cogs, wheels, and pulleys of the Horseracing Integrity and Safety Act (HISA) will work together? To find out, the TDN reached out to Charles Scheeler, chair of the HISA board...

Part One of a Two-Part Series If the letter of the law is any reliable prognosticator, this time next year the United States horse racing industry will already be nearly a month into what promises to be a major realignment of the planets. With the official enactment of the Horseracing Integrity and Safety Act (HISA) on the first of July, 2022, racing jurisdictions North and South, East and West will be bound by the same medication standards, safety rules, and enforcement mechanisms--a hallelujah for many who have long championed the...

The New York State Gaming Commission (NYSGC) uninimoulsy voted to adopt two Thoroughbred-related medication rule changes at its May 17 meeting, although the exact timetable for implementation was not discussed. Pending official adoption of the new rule, clenbuterol use in Thoroughbred racing will be regulated so it follows the model rule proposal of the Racing Medication and Testing Consortium (RMTC). "Clenbuterol, a drug that is ordinarily used in horses as a bronchodilator to treat horses with lower airway disease, also causes a horse's body to build more muscle and reduce...